Abstract
Reduction in sumoylation-dependent S100A4 nuclear import in cholangiocarcinoma by low dose paclitaxel halts tumor invasiveness and hematogenoous metastasization by down-modulating Rho-A and Cdc42 activities
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have